Frovatriptan Succinate

CAS 158930-17-7 3 current recordsSmall Molecule

Who holds supplier records for Frovatriptan Succinate? 3 organisations hold a current record for Frovatriptan Succinate: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (3).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Frovatriptan Succinate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/frovatriptan-succinate

Reading the evidence

  • 3 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    3 of the 3 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (3)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Frovatriptan Succinate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Frovatriptan Succinate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Frovatriptan Succinate is a selective 5-HT receptor agonist used to treat migraine attacks. It has a higher affinity for the 5-HT1B and 5-HT1D receptors, contributing to its efficacy in alleviating headache symptoms.

Chemical identity

IUPAC name
butanedioic acid;(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide;hydrate
Canonical SMILES
CN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N.C(CC(=O)O)C(=O)O.O
InChIKey
CUETXFMONOSVJA-KLQYNRQASA-N
Synonyms
Frova API, frova, frovatriptan succinate hydrate, frovatriptan succinate monohydrate, frovelan, migard, miguard, nsc-760422, sb 209509 ax, sb 209509-ax, sb-209509-ax, sb-209509ax

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Serotonin-1b and Serotonin-1d Receptor Agonist
Mechanism of action
Serotonin 1b Receptor Agonists; Serotonin 1d Receptor Agonists

Therapeutic areas

NeurologyPain Management

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Frovatriptan Succinate?

3 organisations hold an active US FDA Type II Drug Master File or a CEP for Frovatriptan Succinate: ALIVUS LIFE SCIENCES LTD (India), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India) and MATRIX PHARMACORP PRIVATE LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Frovatriptan Succinate Drug Master Files are active?

ALIVUS LIFE SCIENCES LTD (DMF 22952), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 27284) and MATRIX PHARMACORP PRIVATE LTD (DMF 24311). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Frovatriptan Succinate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Frovatriptan Succinate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.